Envoy Medical grants CEO 200K and CFO 15K options at $0.53

Envoy Medical, Inc.

CEO Brent Lucas received options for 200,000 shares; Interim CFO Robert Potashnick received 15,000 shares.
Exercise price set at $0.53 per share (closing price on Feb 5, 2026).
Vesting: 25% after one year, remainder pro rata over next 36 months; options expire 10 years from award date.
Options granted under Envoy Medical's 2023 Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.